Xiangyu Medical Co. Ltd. A Capital Reinvestment Ratio

Latest as of September 2025: 3.23x

Xiangyu Medical Co. Ltd. A capital reinvestment ratio. Xiangyu Medical Co. Ltd. A (688626) has a Capital Reinvestment Ratio of 3.23x as of September 2025, meaning it reinvests 3% of its operating cash flow (CN¥18.05 Million) in capital expenditures (CN¥58.35 Million). Check 688626 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

3.23x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥18.05 Million
CNY

Capital Expenditures

CN¥58.35 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Xiangyu Medical Co. Ltd. A (2017–2024)

Capital reinvestment ratio of Xiangyu Medical Co. Ltd. A from 2017 to 2024. This chart tracks Xiangyu Medical Co. Ltd. A's Capital Reinvestment Ratio across 8 annual periods. Also explore net asset growth rate of Xiangyu Medical Co. Ltd. A to track the company's year-over-year net asset growth rate.

Xiangyu Medical Co. Ltd. A Capital Reinvestment Ratio by Year (2017–2024)

Xiangyu Medical Co. Ltd. A capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see how efficiently does Xiangyu Medical Co. Ltd. A generate cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 2.46x CN¥178.59 Million CN¥438.89 Million ▲ +16.9%
2023 2.10x CN¥227.91 Million CN¥479.26 Million ▲ +93.3%
2022 1.09x CN¥186.70 Million CN¥203.07 Million ▲ +34.7%
2021 0.81x CN¥165.88 Million CN¥133.91 Million ▲ +25.0%
2020 0.65x CN¥216.40 Million CN¥139.71 Million ▲ +377.9%
2019 0.14x CN¥155.94 Million CN¥21.07 Million ▲ +42.9%
2018 0.09x CN¥74.20 Million CN¥7.02 Million ▼ -62.2%
2017 0.25x CN¥59.31 Million CN¥14.84 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow